Central Nervous System (CNS) Therapeutics Market Size to Reach US$ 185.62 Billion During 2022-2027

[{"selector":"#anim-51814147-b26a-44a1-945e-9fd9aef9cebe","keyframes":[{"transform":"scale(1)","offset":0},{"transform":"scale(1.25)","offset":0.33},{"transform":"scale(0.975)","offset":0.66},{"transform":"scale(1)","offset":1}],"delay":0,"duration":1000,"easing":"ease-in-out","fill":"both","iterations":1}] Black Section Separator 1 Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global central nervous system (CNS) therapeutics market size reached US$ 121.56 Billion in 2021.

[{"selector":"#anim-764515a1-32a1-486b-ab26-436014ed6a4c","keyframes":[{"transform":"scale(1)","offset":0},{"transform":"scale(1.25)","offset":0.33},{"transform":"scale(0.975)","offset":0.66},{"transform":"scale(1)","offset":1}],"delay":0,"duration":1000,"easing":"ease-in-out","fill":"both","iterations":1}] Black Section Separator 2 Looking forward, IMARC Group expects the market to reach a value of US$ 185.62 Billion by 2027 exhibiting a growth rate (CAGR) of 7.10% during 2022-2027.

What is central nervous system (CNS) ?

[{"selector":"#anim-08f5eb57-2767-4ff8-a6bb-61759c525d39","keyframes":[{"transform":"scale(1)","offset":0},{"transform":"scale(1.25)","offset":0.33},{"transform":"scale(0.975)","offset":0.66},{"transform":"scale(1)","offset":1}],"delay":0,"duration":1000,"easing":"ease-in-out","fill":"both","iterations":1}] Black Section Separator 3 The central nervous system (CNS) refers to an essential part of the nervous system that comprises of the brain and the spinal cord. It integrates the received information and that coordinates and controls the activities of all parts of the body.

It is extensively adopted in the treatment procedures of Parkinson's disease, depression, Alzheimer's disease, epilepsy, traumatic brain, spinal cord injury, CNS cancer, etc.

[{"selector":"#anim-784291bd-7c1e-42c7-bbad-116616553e80","keyframes":[{"transform":"scale(1)","offset":0},{"transform":"scale(1.25)","offset":0.33},{"transform":"scale(0.975)","offset":0.66},{"transform":"scale(1)","offset":1}],"delay":0,"duration":1000,"easing":"ease-in-out","fill":"both","iterations":1}] Black Section Separator 4

The rising prevalence of mental illnesses and lifestyle-associated nervous system disorders, such as anxiety, depression, hypertension, etc., is among the key factors stimulating the central nervous system (CNS) therapeutics market.

[{"selector":"#anim-d48565b9-160a-439c-a38c-7fd506b843a9","keyframes":[{"transform":"scale(1)","offset":0},{"transform":"scale(1.25)","offset":0.33},{"transform":"scale(0.975)","offset":0.66},{"transform":"scale(1)","offset":1}],"delay":0,"duration":1000,"easing":"ease-in-out","fill":"both","iterations":1}] Black Section Separator 5

Apart from this, the expanding geriatric population, who are more prone to chronic neurological ailments, including Alzheimer's disease and Parkinson's disease, is also propelling the global market.

[{"selector":"#anim-1847a5ea-d4d1-44ef-9703-ecd4ddca33d2","keyframes":[{"transform":"scale(1)","offset":0},{"transform":"scale(1.25)","offset":0.33},{"transform":"scale(0.975)","offset":0.66},{"transform":"scale(1)","offset":1}],"delay":0,"duration":1000,"easing":"ease-in-out","fill":"both","iterations":1}] Black Section Separator 6

Additionally, the growing innovations in nervous system treatment procedures, such as the development of gene therapy, neurostimulation tools, and neural transplantation techniques, are also driving the global market.

[{"selector":"#anim-1ccd80db-0891-44e2-a08f-ed8e1b1c7c5a","keyframes":[{"transform":"scale(1)","offset":0},{"transform":"scale(1.25)","offset":0.33},{"transform":"scale(0.975)","offset":0.66},{"transform":"scale(1)","offset":1}],"delay":0,"duration":1000,"easing":"ease-in-out","fill":"both","iterations":1}] Black Section Separator 7

Apart from this, the launch of favorable guidelines to support faster approvals of pipeline drugs for neurodegenerative diseases and clinical trials that encourage the entry of new products is expected to positively influence the central nervous system (CNS) therapeutics market over the forecasted period.

[{"selector":"#anim-0a46e936-30fd-4c0c-8849-866c63e5623d","keyframes":[{"transform":"scale(1)","offset":0},{"transform":"scale(1.25)","offset":0.33},{"transform":"scale(0.975)","offset":0.66},{"transform":"scale(1)","offset":1}],"delay":0,"duration":1000,"easing":"ease-in-out","fill":"both","iterations":1}] Black Section Separator 8

NEED MORE TransformationStORY

[{"selector":"#anim-0b305410-20e2-4c79-9dff-239004442160","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-84fc8700-220c-4470-b6c9-a7c6d5a03816","keyframes":{"transform":["rotate(15deg) translate3d(83.46154%, 0px, 0) rotate(-15deg)","rotate(15deg) translate3d(0px, 0px, 0) rotate(-15deg)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]